Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)

GlaxoSmithKline Biologicals SA🇨🇳 National Medical Products Administration

Approval Id: 81u8kAc7D5O
Approval Number: 国药准字SJ20150020
Generic Name: 重组乙型肝炎疫苗(酿酒酵母)
Generic Name En: Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)
Trade Name: 安在时
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 20μg/1.0ml/支
Reg Date: 2025-04-15
Expired Date: 2030-04-14
Company Name: GlaxoSmithKline Biologicals SA
Production Company Name: GlaxoSmithKline Biologicals SA
Company Detail Path: /organization/glaxosmithkline-biologicals-sa
Production Company Detail Path: /organization/glaxosmithkline-biologicals-sa

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 15, 2025

Approval ID

81u8kAc7D5O

Type

生物制品